GlassScriptPhysician profile
Thomas Dardarian
NPI 1013095413
$3,286.06
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $178 · 2021: $506 · 2022: $898 · 2023: $689 · 2024: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $725.94 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Caldera Medical, INC | $270.24 | 2024 | Desara |
| Aspira Women'S Health INC | $255.24 | 2021 | |
| Exeltis, USA INC. | $215.91 | 2019-2023 | Slynd |
| Hologic Sales and Service, LLC | $199.87 | 2019-2022 | |
| Therapeuticsmd, INC. | $198.69 | 2021-2022 | |
| Myovant Sciences INC. | $156.28 | 2021-2022 | |
| Astellas Pharma US INC | $133.01 | 2023-2024 | Veozah |
| Pfizer INC. | $129.28 | 2022-2023 | |
| Tactile Systems Technology INC | $121.87 | 2019 | |
| Mayne Pharma Commercial LLC | $118.07 | 2022-2023 | |
| Smith+Nephew, INC. | $114.42 | 2019 | |
| Organon LLC | $77.58 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $77.30 | 2019-2022 | |
| Coopersurgical, INC. | $74.37 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $56.18 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $51.39 | 2020-2022 | |
| Medtronic, INC. | $39.52 | 2022-2023 | Truclear |
| Sumitomo Pharma America, INC. | $33.07 | 2023 | Myfembree |
| Millicent US INC | $32.65 | 2019-2020 | |
| Exact Sciences Corporation | $30.70 | 2023 | Cologuard Collection Kit |
| Henry Schein, INC. | $28.09 | 2024 | |
| Avion Pharmaceuticals | $26.28 | 2021 | |
| Sage Therapeutics, LLC | $22.78 | 2022 | |
| Lupin INC. | $18.80 | 2020 | |
| Duchesnay USA Incorporated | $18.47 | 2022 | |
| Convatec INC. | $17.53 | 2019 | |
| Amgen INC. | $15.14 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.37 | 2020 | |
| Agile Therapeutics, INC. | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dardarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.